Skip to main content

Mintz Advises Underwriters of Viking’s $287.5 Million Public Offering of Common Stock

NEW YORK – Mintz represented the syndicate of underwriters led by William Blair & Company, L.L.C., in the public offering of 17,242,000 shares of common stock of Viking Therapeutics, Inc. (“Viking”) (Nasdaq: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, at an initial offering price of $14.50 per share.

The underwriters were granted, and have exercised, a 30-day option to purchase up to 2,586,300 additional shares of common stock on the same terms and conditions.

The gross proceeds of the offering, before deducting underwriting discounts and commissions and offering expenses, were $287.5 million, including the full exercise of the underwriters’ option to purchase additional shares. The offering closed on April 3, 2023.

William Blair & Company, L.L.C. acted as lead book-running manager and Raymond James & Associates, Inc. acted as joint book-running manager for the offering. Truist Securities, Inc., BTIG, LLC, Oppenheimer & Co. Inc. and H.C. Wainwright & Co., LLC also acted as bookrunners for the offering. Maxim Group LLC, Roth Capital Partners, LLC and Laidlaw & Company (UK) Ltd. acted as co-managers.

The Mintz capital markets team representing the underwriters was led by Member Michael Maline and included Of Counsel Jeffrey Cohan and Associate Daniel Lerner. Advice was also provided on intellectual property matters by Member Terri Shieh-Newton, Ph.D. and Contract Attorney Evelyne Guillouet; regulatory diligence matters by Of Counsel Benjamin Zegarelli; and, generally, by Law Clerk, Kim Green.

Mintz’s Securities and Capital Markets attorneys represent 50+ domestic and international public companies and help them navigate the challenges of life as a public company. Our experience includes representing our clients in hundreds of initial public offerings (IPOs) and follow-on offerings in the public equity market, assisting our clients in navigating the complex disclosure requirements involved in public company reporting, Sarbanes-Oxley and Dodd-Frank Act compliance, corporate governance, shareholder relations, equity compensation planning, and board and committee-level counsel and strategic advice.

For more information about Mintz, please visit